Phivos Symeonides

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens et al. · Atherosclerosis · 2018 · 228 citations · Full text

Family Medicine, Lipid Disorder, Primary Care +9

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens et al. · The Lancet · 2023 · 71 citations · Full text

Comparison of the Effects of Ramipril Versus Telmisartan in Reducing Serum Levels of High-Sensitivity C-Reactive Protein and Oxidized Low-Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes Mellitus

Spyridon Koulouris, Phivos Symeonides, Konstantinos Triantafyllou et al. · The American Journal of Cardiology · 2005 · 61 citations

Metabolic Syndrome, Cardiovascular Disease, Medicine +8

Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study

Phivos Symeonides, S KOULOURIS, Ekaterini Vratsista et al. · European Journal of Echocardiography · 2006 · 37 citations